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Abstract
Background: Siglec-7, a sialic acid binding inhibitory receptor expressed by NK cells is masked in
vivo by a so far unknown ligand. It shows a strong binding prevalence for α-2,8-linked disialic acids
in vitro.
Results: Here we describe the expression of PSA-NCAM (α-2,8-linked polysialic acid modified
NCAM) on functional adult peripheral blood natural killer cells and examine its possible role in
masking Siglec-7. Unmasking of Siglec-7 using Clostridium perfringens neuraminidase massively
reduces NK cell cytotoxicity. By contrast a specific removal of PSA using Endo-NF does not lead
to a reduction of NK cell cytotoxicity.
Conclusion: The results presented here therefore indicate that PSA-NCAM is not involved in
masking Siglec-7.
Background
Siglec-7 (p75/AIRM1) is a sialic acid binding inhibitory
receptor expressed on NK and NKT cells and to a lesser
extend also on monocytes [1]. It shows a prevalence for
binding α-2,8-linked or branched α-2,6-linked sialic acids
in vitro and is constitutively masked by a endogenous lig-
and in vivo [2] which has not been identified yet. It has
been shown that trans-activation of unmasked Siglec-7
leads to an inhibition of NK cell cytotoxicity [2,3]. Natural
killer cells are characterized by the expression of CD56
(neural cell adhesion molecule, NCAM). NCAM is an
immunoglobulin-like cell adhesion molecule (IgCAM)
and was the first vertebrate protein demonstrated to be
glycosylated with polysialic acid (PSA), which is a homo-
meric polymer of α-2,8-sialic acid. Until now only very
few proteins have been reported to be modified with PSA
[4,5].
Our question was whether CD56 on NK cells is polysia-
lylated and if PSA-NCAM could be the endogenous ligand
masking Siglec-7. For this purpose we performed a FACS
analysis examining PSA expression on peripheral blood.
The impact of PSA on NK cell cytotoxicity was determined
by killing assays after specific enzymatic removal of sialic
acids.
Results
Detection of PSA expression in human peripheral blood
To detect PSA+ cells in peripheral blood we used an anti-
body which binds PSA of at least twelve α-2,8-linked sialic
acid residues [6,7]. Co-staining of PSA and CD56 not only
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shows co-expression but also a strong correlation of stain-
ing intensity, which indicates that CD56 on NK cells, is
polysialylated (Fig. 1A). Co-expression of PSA and CD56
was also verified by immunocytochemical staining (Fig.
1B). Polysialylation of NCAM on NK cells has also been
suggested by Lanier et al. who sowed excessive sialylation
of NCAM, but the nature of the linking of sialic acid mon-
omers was not investigated [8].
To exclude PSA expression by other hematopoietic cell
lineages we compared expression of CD56 with anti PSA
staining. For this purpose co-stainings with several lineage
markers for T cells (CD3, CD4, CD8), monocytes (CD14),
B cells (CD19), NK cells (CD56), dendritic cells and
basophiles (CD123) and stem cells (CD133) were per-
formed. FACS analysis showed PSA staining on
CD56+cells and on small subpopulations of CD3+ and
CD8+ cells, which also express CD56 (Fig. 2). Our data
indicates that PSA-NCAM is expressed by NK and NKT
cells, cell types which are also known to express siglec-7
[1].
Characterization of polysialyltransferase expression in NK 
cells
Two enzymes have been shown to be independently able
to synthesize PSA, the polysialyltransferases SIAT8D
(ST8SiaIV, PST) and SIAT8B (ST8SiaII, STX). To determine
which polysialylating enzymes are involved in the expres-
sion of PSA on NK cells reverse transcriptase PCR was per-
formed. We compared SIAT8D and SIAT8B mRNA
expression in adult CD56+ NK cells and in human adult
and fetal brain. Expression of SIAT8D was found in NK
cells as well as in both brain samples. In contrast SIAT8B
was expressed predominantly in fetal brain, but the
expression was drastically reduced in adult brain and
could not be detected in adult NK cells (Fig. 3). These
findings suggest that only SIAT8D contributes to NCAM
polysialylation in peripheral blood NK cells. SIAT8D
expression by NK cells was also reported recently by Avril
and colleagues [9].
Functionality of NK cells after separation via PSA
In order to provide functional evidence, PSA+ cells and via
CD56 isolated NK cells were compared using K562 killing
assays. As shown in Fig. 4A, cells separated either via
CD56 or PSA show expression of PSA. Separated cells
were co-cultured with the target cell line K562 for four
hours followed by a killing efficiency determination. A
comparative killing assay showed only a small difference
in killing efficiency (Fig. 4B). Comparison of killing effi-
ciencies at the effector target ratio 50:1 showed no signif-
icant reduction of killing ability by the separation strategy
(Fig. 4C). The slightly reduced killing efficiency of cells
separated via PSA could be caused by the large labeling
complex (anti PSA + anti IgM.PE + anti PE microbeads)
due to steric inhibition. These data indicate that cells sep-
arated via PSA are functional NK cells.
Impact of PSA expression on NK cell function
To investigate the potential impact of polysialic acid on
the killing ability of NK cells, sialic acid residues were
removed enzymatically with Clostridium perfringens neu-
raminidase or Endo-NF and NK cells were again tested in
a killing assay. Clostridium perfringens neuraminidase is
able to remove all sialic acid residues (α-2,3, α-2,6 and α-
2,8-linked sialic acids) from the cell surface while Endo-
NF removes only α-2,8-linked sialic acid residues. After
enzymatic treatment the vitality was not reduced signifi-
cantly (91% after neuraminidase treatment in compari-
son to 96.7% without neuraminidase treatment, Fig. 5D;
and 93,5% after Endo-NF treatment and 97,5% without
treatment, Fig. 6D). As can be seen in Fig 5A and 6A only
few PSA expressing cells are remaining after neuramini-
dase or Endo-NF treatment. Only 5% of neuraminidase
treated cells and 2% of Endo-NF treated cells show re-
expression of PSA on the cell surface after 4 h culture in
RPMI/2 mM L-Glutamine/10% FCS (data not shown)
indicating that PSA is only weakly re-expressed during the
killing assay. The comparative killing assay revealed a
strongly reduced killing efficiency of neuraminidase
treated NK cells (Fig. 5B). Comparison of killing efficien-
cies at the target effector ratio 1:50 showed a highly signif-
icant reduction of killing ability of NK cells after
neuraminidase treatment (Fig. 5C) while Endo-NF treat-
ment had no impact on the killing efficiency (Fig 6B/C).
Discussion
The role of PSA-NCAM in the developing brain is well
characterized, whereas only little is known about PSA-
NCAM expression and function in other organs.
The results presented here show PSA-NCAM expression
on functional human peripheral blood NK cells, which
can be isolated via PSA without loss of function.
Phenotyping experiments with several lineage markers for
T cells (CD3, CD4, CD8), monocytes (CD14), B cells
(CD19), NK cells (CD56), dendritic cells and basophiles
(CD123) and stem cells (CD133) demonstrated expres-
sion of PSA on CD56+/CD45+ NK cells and on CD3+/
CD8+/CD45+/CD56+ NKT cells.
Functionality of PSA+ cells was analyzed using killing
assays, showing that NK cells separated according to their
expression of PSA showed only a slightly reduced killing
capacity compared to NK cells separated using CD56
microbeads. The large labeling complex used to isolate
PSA+ cells could cause this reduction due to steric inhibi-
tion. PSA expression has also been described on decidual
NK cells (dNK cells) [10] which are located in the humanBMC Immunology 2007, 8:13 http://www.biomedcentral.com/1471-2172/8/13
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placenta where they play an important role in maintain-
ing pregnancy. In contrast to peripheral blood derived NK
cells dNK cells show only week cytotoxicity. And as their
expression pattern differs from peripheral blood NK cells,
even a different NK cell lineage arising from a different
progenitor was suggested [11].
PCR analysis of the expression of the two polysialyltrans-
ferases SIAT8D and SIAT8B showed that NK cells only
express SIAT8D. It has been shown that SIAT8D plays a
predominant role in NCAM polysialylation and that
mRNA levels strongly correlate with protein expression
[12]. We could show that SIAT8D is strongly expressed on
mRNA level in NK cells, which suggests that SIAT8D is the
main polysialylating enzyme in adult NK cells. Its expres-
sion also provides additional evidence for polysialylation
of NCAM.
As has been described before, enzymatic removal of all
sialic acid residues with Clostridium perfringens Neuramin-
NK cells express PSA-NCAM Figure 1
NK cells express PSA-NCAM. (A) FACS analysis of co-expression of PSA and CD56 in peripheral blood mononuclear cells 
shows a strong correlation of staining intensities. Data shown are representative of several independent experiments. (B) 
Expression of PSA (red) and CD56 (green) by NK cells examined via confocal microscopy. Rectangle indicates an unlabeled 
PBMC cell.BMC Immunology 2007, 8:13 http://www.biomedcentral.com/1471-2172/8/13
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Expression of PSA and CD56 in peripheral blood Figure 2
Expression of PSA and CD56 in peripheral blood. FACS analysis of PSA and CD56 expression in PBMC via co-staining 
with CD3, CD4, CD8, CD14, CD19, CD45, CD56, CD123 and CD133.BMC Immunology 2007, 8:13 http://www.biomedcentral.com/1471-2172/8/13
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idase reduced the killing efficiency of CD56+ cells dramat-
ically due to de-masking of siglec-7 [2]. However Endo-NF
treatment of NK cells did not lead to a reduction of killing
efficiency. A reduction of PSA polymerization degree is
supposed to have a major effect on PSA function. We thus
conclude that PSA is not involved in masking Siglec-7.
Removal of PSA using Endo-NF creates a rest of four α-
2,8-linked sialic acid residues [13]. The PSA antibody
(Men-B) used in the experiments above recognizes PSA of
a minimum chain length of twelve sialic acid residues
[14]. We thus conclude that after Endo-NF treatment a
minimum of four and a maximum of eleven α-2,8-linked
sialic acid residues are still left on the NK cell surface. The
fact that removal of sialic acid residues with Endo-NF does
not lead to a reduced cytotoxicity of NK cells gives rise to
the speculation that the unknown endogenous ligand of
Siglec-7 consists either of maximal four α-2,8-linked sialic
acid residues or α-2,6-linked branched sialic acid residues.
Other candidates for the masking ligand of Siglec-7 have
already been identified. Avril et al. for example showed
recently expression of a so far uncharacterized α-2,8-disi-
alylated O-linked glycan by NK cells [9].
The role of PSA-NCAM on NK cells remains unknown.
PSA-NCAM has been characterized in the nervous system,
where it has an impact on cell migration, axonal path
finding, neurite outgrowth, fasciculation of neurites and
also modulates AMPA receptors [15] (for NCAM and PSA-
NCAM interactions and signal transduction see [16] for
review). Muscle cells, including cardiac myocytes also
express PSA-NCAM during development. Furthermore
PSA can directly modulate the homophilic binding poten-
tial of NCAM [17] and also interactions with other pro-
teins. And Agrin, a heparan sulfate proteoglycan of the
extracellular matrix has been suggested to bind the
heparin-binding site of NCAM and PSA [18]. Signaling of
brain-derived neurotrophic factor (BDNF) [19] and plate-
let derived growth factor (PDGF) [20] is affected by the
PSA moieties bound to NCAM.
Conclusion
In conclusion we could show expression of PSA-NCAM
on functional human peripheral blood NK cells. Our data
strongly indicates that the polysialyltransferase SIAT8D is
responsible for PSA expression in NK cells. Killing assays
after specific removal of PSA revealed that elimination of
PSA has no effect on NK cell cytotoxicity and thus indicate




K562 cell line was cultured in RPMI (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany), 10% FCS (PAA,
Brisbane, Australia), 2 mM L-Glutamine (Gibco, Paisley,
Scotland, UK) and 1% Penicillin-Streptomycin (10,000
U/ml, Gibco) at 37°C, 5% CO2. Medium was changed
twice weekly.
Flow cytometric analysis
For flow cytometric analysis Fc receptors were blocked
with FCR Blocking Reagent (Miltenyi Biotec GmbH) and
incubated for 10 minutes at 4–8°C with an anti PSA mon-
oclonal antibody (clone MenB, 2 μg/ml). After washing
once with PBS/2 mM EDTA cells were incubated with a
phycoerythrin (PE) conjugated anti IgM monoclonal anti-
body (clone X-54) or a PE conjugated anti CD56 mono-
clonal antibody (clone AF12-7H3, all Miltenyi Biotec
GmbH) and the following antibodies: FITC (fluorescein
isothiocyanate) conjugated anti CD4 (clone M-T321),
anti CD14 (clone TÜK4), anti CD123 (clone AC145),
allophycocyanin (APC) conjugated anti CD8 (clone
BW135/80), anti CD16 (clone VEP13), anti CD19 (clone
LT19), anti CD45 (clone 5B1), anti CD133 (clone
293C3), anti CD335 (clone 9E2) (all Miltenyi Biotec
GmbH). For CD3 co-staining an anti CD3-APC (clone
SK7, BD Bioscience, San Diego, CA, USA) was used. FACS
analysis after cell separation was done using a FITC conju-
Analysis of polysialyltransferase expression Figure 3
Analysis of polysialyltransferase expression. PCR anal-
ysis of cDNA derived from CD56+ NK cells and human fetal 
and adult brain regarding their expression of NCAM and the 
two polysialyltransferases SIAT8D and SIAT8B. cDNA con-
centration was normalized via the β-actin housekeeping gene.BMC Immunology 2007, 8:13 http://www.biomedcentral.com/1471-2172/8/13
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gated anti CD56 (clone NCAM16.2, BD Pharmingen, BD
Bioscience, San Diego, CA, USA). Isotype controls were
purchased from Pharmingen, BD Bioscience.
FACS analysis was performed using a FACS Calibur flow
cytometer (Becton Dickinson, Heidelberg, Germany).
Dead cells were excluded via propidium iodide staining.
Data analysis was performed with BD CELLQuest soft-
ware.
Immunocytochemistry
Untouched NK cells were isolated from peripheral blood
mononuclear cells (PBMC) using the NK Cell Isolation Kit
II (Miltenyi Biotec GmbH) according to manufacturer's
instructions.
In order to show specificity of immunocytochemical
staining 1 × 106 PBMC were added to 1 × 106 cells of the
positive fraction and the cells were fixed with 3.7% neu-
tral buffered formalin for 10 minutes at room tempera-
ture. After washing twice, unspecific binding sites were
blocked by incubation with PBS/5% normal goat serum
(Vector Laboratories, Burlingame, CA, USA) and cells
were incubated with anti PSA (Clone MenB, 2 μg/ml) and
anti CD56 (clone AF12-3H7, 5 μg/ml, Miltenyi Biotec
GmbH) for 1 hour at 4–8°C. After washing twice with
PBS/5% normal goat serum, cells were incubated with rat
anti murine IgG1-Alexa488 (clone CLX56, labeled using
the Alexa Fluor 488 Protein Labelling Kit, Molecular
Probes, Invitrogen, Karlsruhe, Germany) and goat anti rat
IgM-RhodamineX (clone C48-6, 1:500, Pharmingen, BD
Bioscience) for 1 hour at 4–8°C. After washing with PBS/
5% normal goat serum, 2 × 105 cells were spun onto
microscope slides using a Shandon Cytospin 3 Cytocentri-
fuge (Thermo Electron Corp., Waltham, MA, USA) at 800
rpm for 5 minutes, mounted with Fluoromount G (South-
PSA+ cells are functional NK cells Figure 4
PSA+ cells are functional NK cells. (A) PSA expression on cells isolated via PSA or CD56. (B) NK cells isolated either via 
CD56 or PSA were assessed for their ability to lyse K562 target cells in a 4 h-killing assay. Data shown are the average mean ± 
SEM from one out of three independent experiments. (C) Comparison of killing efficiencies at the effector target ratio 50:1. 
Data shown are the average mean ± SEM from three independent experiments (p < 0.001). Control refers to the vitality of the 
K562 cell line alone.BMC Immunology 2007, 8:13 http://www.biomedcentral.com/1471-2172/8/13
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ern Biotech, Birmingham, USA) and analysed with a Leica
DMIRE2 confocal microscope (Leica Microsystems, Wet-
zlar, Germany) using Leica Confocal Software.
Isolation of CD 56+ and PSA+ cells
CD56+ and PSA+ cells were separated from PBMC using
the MACS technology (Miltenyi Biotec GmbH). Briefly,
cells were incubated with magnetic bead conjugated
CD56 monoclonal antibody (clone AF12-7H3, Miltenyi
Biotec GmbH) and separated over one MS column. The
purity ranged from 91.3% to 98.3% (average 95.7%) and
was checked by FACS analysis using anti PSA (clone
MenB), anti IgM-PE (clone X54) and anti CD56.FITC
(clone NCAM16.2).
PSA+ cells were separated using an anti PSA monoclonal
antibody (clone MenB). Subsequently, cells were incu-
bated with a PE conjugated anti IgM secondary antibody
(clone X54) and magnetic labeling was performed using
anti PE microbeads (Miltenyi Biotec GmbH). Cells were
separated over two MS columns and the purity ranged
from 91.4% to 96.1% (average 94.5%).
K562 killing assay
The killing efficiency of CD56+ cells and PSA+ cells was
determined via the killing of the MHC I&II negative target
cell line K562.
K562 cells were labeled with CFDA-SE (carbofluorescein
diacetate succinimidylester, 2.5 ng/ml, Molecular Probes)
in medium without FCS. After two minutes the labeling
reaction was stopped by adding FCS, followed by a wash-
ing step. Then the cells were incubated in cell culture
medium until needed.
Neuraminidase treatment reduces NK cell cytotoxicity Figure 5
Neuraminidase treatment reduces NK cell cytotoxicity. (A) FACS analysis of PSA expression with and without Clostrid-
ium perfringens Neuraminidase treatment. (B) CD56+ cells with and without Neuraminidase treatment were investigated in a 4 
h-killing assay. Data shown are the average mean ± SEM from one out of three independent experiments (C) Comparison of 
killing efficiencies at the target effector ratio 1:50 shows a significant reduction of cytotoxicity after Neuraminidase treatment. 
Data shown are the average mean ± SEM from three independent experiments (p = 0.0025). Control refers to the killing effi-
ciency of untreated NK cells. (D) Comparison of vitality with and without neuraminidase treatment shows no significant differ-
ence. Data shown are the average mean ± SEM from three independent experiments.BMC Immunology 2007, 8:13 http://www.biomedcentral.com/1471-2172/8/13
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The target cells were incubated with CD56+ or PSA+ cells in
the target effector ratios 1:10, 1:20, 1:50 and 1:100 in
complete medium at 37°C. After 4 h the killing reaction
was stopped by putting the cells on ice. The cells were ana-
lyzed by FACS analysis and dead cells were discriminated
using propidium iodide. Data analysis was performed by
BD CELLQuest software. The killing efficiency was deter-
mined by the ratio of the number of dead CFDA-SE+ cells
to the total number of CFDA-SE+ cells.
Reverse transcriptase PCR
Total RNA of 1 × 106 CD56+ cells was extracted using the
NucleoSpin RNA II Kit (Macherey & Nagel, Dueren, Ger-
many) according to the manufacturer's instructions.
cDNA was synthesized in a 30 μl reaction mixture con-
taining 300 U SuperscriptII, 1× first strand buffer (0.3 μM,
Invitrogen), dNTP (200 μM each, PEQLAB, Erlangen, Ger-
many), Oligo(dT)18 (5 μg) and (N6) random hexamere
(0.2 μg, both Metabion, Martinsried, Germany).
Human normal adult brain cDNA (1 μl per PCR reaction)
and human fetal brain cDNA (2 μl per PCR reaction) were
purchased from Biochain Institute, Inc (Hayward, CA,
USA).
PCR was performed in a 50 μl reaction mixture containing
1.25 units Taq polymerase, 1× reaction buffer, 2 mM
MgCl2 (Fermentas International Inc., Burlington, Ontario,
Canada), 200 μM of each dNTP (PEQLAB, Erlangen, Ger-
many) and 200 nM primers (Metabion). cDNA concentra-
tions were normalized via the β-actin housekeeping gene.
The following primers were used: SIAT8B (forward: agac-
ctggtaaccatgaaccc, reverse: tgggaggtgtagccatacttg), SIAT8D
(forward: ccaatgaagaatcgcaggtt, reverse: cttagggaagggcca-
Endo-NF treatment has no impact on NK cell cytotoxicity Figure 6
Endo-NF treatment has no impact on NK cell cytotoxicity. (A) FACS analysis of PSA expression with and without 
Endo-NF treatment. (B) NK cells separated via CD56 were investigated in a 4 h-killing assay with and without Endo-NF treat-
ment. Data shown are the average mean ± SEM from one out of three independent experiments. (C) Comparison of killing effi-
ciencies at the target effector ratio 1:50 shows no difference of treated and untreated cells. Data shown are the average mean 
± SEM from three independent experiments. Control refers to the killing efficiency of untreated NK cells. (D) Comparison of 
vitality with and without Endo-NF treatment shows no significant loss of vitality. Data shown are the average mean ± SEM from 
three independent experiments.BMC Immunology 2007, 8:13 http://www.biomedcentral.com/1471-2172/8/13
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gaatc), β-actin (forward: gagaagatgacccagatcatgt, reverse:
catctcttgctcgaagtccag).
The cycling conditions comprised an initial denaturation
of 5 min at 94°C and 30 cycles of 1 min at 94°C, 1 min at
60°C and 1 min at 72°C followed by a final elongation of
10 min at 72°C.
Enzymatic treatment
2 × 106 CD56+ cells/ml were cultured in RPMI/10% FCS/
2 mM L-glutamine containing 0.125 U/ml Clostridium per-
fringens  Neuraminidase type V (Sigma Chemical Co.,
Deisendorf, Germany) or 1.5 ng/ml Endo-NF derived
from NF bacteriophage (kind gift from M. Mühlenhoff,
Medizinische Hochschule Hannover, Hannover, Ger-
many) for 12 h to 16 h. Untreated CD56+ cells were cul-
tured in RPMI/10% FCS/2 mM L-glutamine at 37°C, 5%
CO2.
Statistics
Statistical significance of the killing efficiency of NK cells
isolated via their CD56 or PSA expression was determined
using two-way ANOVA followed by post hoc t-test with
Bonferroni correction. Statistical significances of the kill-
ing efficiency and the vitality of CD56+ NK cells with and
without enzymatic treatment were determined by
unpaired t-test. Differences between two conditions at p <
0.05 were considered as statistically significant.
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